We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gilead Sciences Unveils Final Results From Remdesivir Trial Showing It Helped COVID-19 Patients
Gilead Sciences Unveils Final Results From Remdesivir Trial Showing It Helped COVID-19 Patients
Gilead Sciences has released the final results from a late-stage trial of its investigational antiviral remdesivir, which showed that the drug helped patients improve in multiple areas compared to placebo and worked one day faster than previous data showed.